Literature DB >> 8757618

Transduction of specific inhibition of HuT 78 human T cell chemotaxis by type I vasoactive intestinal peptide receptors.

M Xia1, G O Gaufo, Q Wang, S P Sreedharan, E J Goetzl.   

Abstract

The major immunoregulatory effects of vasoactive intestinal peptide (VIP) are mediated by structurally distinct types I (VIPR1) and II (VIPR2) G protein-associated receptors on some T cells, B cells, and macrophages. Identification of the separate immunologic activities of each type of VIPR has been complicated by the usual expression of only VIPR2 or of VIPR1 and VIPR2 together by most human T cells obtainable in sufficient number for functional analyses. The results of reverse-transcription PCR, Western blot, and [125I]VIP-binding studies have established that HuT 78 cultured human lymphoma T cells bear a mean of 75,000 VIPR1s per cell with a mean Kd of 3.3 nM, which transduce mean maximal increases in intracellular concentration of cAMP of 2.1-fold (ED50 = 72 nM), but no VIPR2s. HuT 78 T cells, in contrast to T cells that express VIPR2, did not respond to VIP by chemotaxis through micropore filters without or with a top layer of basement membrane-like Matrigel. Matrix metalloproteinase (MMP)-dependent in situ cleavage of [3H]type IV human collagen in the layer of Matrigel by HuT 78 T cells also was not stimulated by VIP. In contrast, IL-4 and TNF-alpha both stimulated HuT 78 T cell chemotaxis and in situ MMP activity at respective optimal concentrations ranging from 3 x 10(-10) M to 3 x 10(-9) M and 10(-10) M to 3 x 10(-10) M. VIP inhibited significantly HuT 78 T cell chemotaxis through Matrigel in response to both IL-4 and TNF-alpha, as a result of suppression of both chemotactic mobility, assessed by migration through micropore filters without Matrigel, and in situ MMP activity. The transduction of opposite effects of VIP on T cell migration through a model basement membrane by VIPR1 and VIPR2 suggests that the net chemotactic response of most T cells to VIP is determined by the VIPR2/VIPR1 ratio and that the predominant expression of VIPR1 would stabilize T cell populations in lymphoid follicles and tissue infiltrates.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757618

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis.

Authors:  Catalina Abad; Yossan-Var Tan; Robert Lopez; Hiroko Nobuta; Hongmei Dong; Phu Phan; Ji-Ming Feng; Anthony T Campagnoni; James A Waschek
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-26       Impact factor: 11.205

2.  Vasoactive intestinal peptide signaling axis in human leukemia.

Authors:  Glenn Paul Dorsam; Keith Benton; Jarrett Failing; Sandeep Batra
Journal:  World J Biol Chem       Date:  2011-06-26

3.  Infiltrative capacity of T leukemia cell lines: a distinct functional property coupled to expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1).

Authors:  A Ivanoff; J Ivanoff; K Hultenby; K G Sundqvist
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

4.  Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection.

Authors:  Eva Hedlund; Martin Karlsson; Teresia Osborn; Wesley Ludwig; Ole Isacson
Journal:  Brain       Date:  2010-08       Impact factor: 13.501

5.  CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1.

Authors:  Thomas T Murooka; Ramtin Rahbar; Leonidas C Platanias; Eleanor N Fish
Journal:  Blood       Date:  2008-03-12       Impact factor: 22.113

6.  Inhibitors of Human Neuraminidase Enzymes Block Transmigration in vitro.

Authors:  Md Amran Howlader; Tianlin Guo; Christopher W Cairo
Journal:  Front Mol Biosci       Date:  2022-02-25

7.  Ccl5 Mediates Proper Wiring of Feedforward and Lateral Inhibition Pathways in the Inner Retina.

Authors:  D'Anne S Duncan; Rebecca L Weiner; Carl Weitlauf; Michael L Risner; Abigail L Roux; Emily R Sanford; Cathryn R Formichella; Rebecca M Sappington
Journal:  Front Neurosci       Date:  2018-10-12       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.